Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xubin Li

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Cancer Discovery|April 12, 2022
Precision Combination Therapies Based on Recurrent Oncogenic CoalterationsXubin Li, Elisabeth K Dowling, Gonghong Yan, et al.
Oncotarget|November 27, 2016
Recombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IVPeipei Xing, Jin Zhang, Zhao Yan, et al.
Cell Reports|September 14, 2022
BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancerGonghong Yan, Augustin Luna, Heping Wang, et al.
Nature Genetics|October 21, 2025
Multi-modal spatial characterization of tumor immune microenvironments identifies targetable inflammatory niches in diffuse large B cell lymphomaYibo Dai, Atish Kizhakeyil, Dai Chihara, et al.
Cancer Cell|March 8, 2024
SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisionsQing Deng, Priya Lakra, Panhong Gou, et al.
Blood Advances|June 30, 2023
A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphomaPaolo Strati, Andrew Jallouk, Qing Deng, et al.
Cell Reports. Medicine|August 16, 2023
Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cellsPaolo Strati, Xubin Li, Qing Deng, et al.
Cancer Cell|September 8, 2025
Large B cell lymphoma microenvironment archetype profilesXubin Li, Kartik Singhal, Qing Deng, et al.
Blood Cancer Discovery|June 10, 2022
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II ExpressionGuangchun Han, Qing Deng, Mario L Marques-Piubelli, et al.
Cancer Cell|June 4, 2026
Pathogenesis of diffuse large B cell lymphoma proteogenotypesJulius C Enssle, Björn Häupl, Arber Qoku, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Cancer Discovery|April 12, 2022
Precision Combination Therapies Based on Recurrent Oncogenic CoalterationsXubin Li, Elisabeth K Dowling, Gonghong Yan, et al.
Oncotarget|November 27, 2016
Recombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IVPeipei Xing, Jin Zhang, Zhao Yan, et al.
Cell Reports|September 14, 2022
BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancerGonghong Yan, Augustin Luna, Heping Wang, et al.
Nature Genetics|October 21, 2025
Multi-modal spatial characterization of tumor immune microenvironments identifies targetable inflammatory niches in diffuse large B cell lymphomaYibo Dai, Atish Kizhakeyil, Dai Chihara, et al.
Cancer Cell|March 8, 2024
SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisionsQing Deng, Priya Lakra, Panhong Gou, et al.
Blood Advances|June 30, 2023
A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphomaPaolo Strati, Andrew Jallouk, Qing Deng, et al.
Cell Reports. Medicine|August 16, 2023
Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cellsPaolo Strati, Xubin Li, Qing Deng, et al.
Cancer Cell|September 8, 2025
Large B cell lymphoma microenvironment archetype profilesXubin Li, Kartik Singhal, Qing Deng, et al.
Blood Cancer Discovery|June 10, 2022
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II ExpressionGuangchun Han, Qing Deng, Mario L Marques-Piubelli, et al.
Cancer Cell|June 4, 2026
Pathogenesis of diffuse large B cell lymphoma proteogenotypesJulius C Enssle, Björn Häupl, Arber Qoku, et al.
Pageof 8